Angiotech Pharmaceuticals
Corza Medical is a global medical technology company selling surgical devices and consumables — biosurgery, biomedical textiles, ophthalmology, and wound closure products — to hospitals, surgical centers, and OEM partners in 80+ countries.
- Company typePrivate
- Founded1975
- HeadquartersVancouver, Canada
- Headcount1,001–5,000
- GTM typeB2B
- OfferingHardware or Manufacturing
What Angiotech Pharmaceuticals does
Corza Medical, the successor entity to the medical technology business of Angiotech Pharmaceuticals (founded 1989 in Vancouver, BC), operates as a global medical technology company headquartered in Boulder, Colorado, with international headquarters in Switzerland and an Asia-Pacific headquarters in China. The company designs, manufactures, and distributes surgical medical devices across four product verticals: Biosurgery (notably TachoSil, a hemostatic sealing pad), Biomedical Textiles (Pearsalls-branded OEM textile products), Ophthalmology (Katena reusable surgical instruments, the SensorTek ROP Kit, and the Onatec suture portfolio), and Wound Closure (Quill barbed sutures, Express Gut, and Sharpoint sutures). Manufacturing is conducted at seven global locations, and the company maintains a commercial presence in 80+ countries.
The business model is primarily B2B hardware sales of surgical consumables and instruments to hospitals, surgical centers, and specialty clinics. Revenue is generated through field sales teams organized by product category, supplemented by e-commerce storefronts for smaller practices (Wound Closure Store, Ophthalmology Store) and a recently launched enterprise customer portal (corzaeye.com) for ophthalmology customers. Pricing is quote-based for institutional customers and not publicly disclosed. The company cites 200+ years of combined innovation heritage across its portfolio of brands.
Customer segmentation is vertical-driven: Surgical Hospitals and Medical Centers, Ophthalmology Practices, Surgical Specialists (general, orthopedic, cosmetic), and OEM Partners served through a recently launched Biomedical Textiles Innovation Lab for textile-based prototyping. End-customer evidence includes named surgeons in cosmetic facial surgery, orthopedic surgery, and optometry, with testimonials emphasizing price-quality positioning against incumbent brands such as Ethicon. The company reports approximately $500M+ in annual revenue and a workforce of 3000+ employees.
Angiotech Pharmaceuticals firmographics
Firmographics- Name
- Angiotech Pharmaceuticals
- Legal name
- Corza Medical
- Website
- https://surgicalspecialties.com
- Company type
- Private
- Founded year
- 1975
- Operating status
- Operating
- Headcount range
- 1,001–5,000 employees
- Short description
- Corza Medical is a global medical technology company selling surgical devices and consumables — biosurgery, biomedical textiles, ophthalmology, and wound closure products — to hospitals, surgical centers, and OEM partners in 80+ countries.
- Ownership category
- akta.pro rank
Angiotech Pharmaceuticals industry classification
Industry- Product category
- Surgical Medical Devices
- NAICS
- Surgical and Medical Instrument Manufacturing (339112), Surgical Appliance and Supplies Manufacturing (339113), Medical Equipment and Supplies Manufacturing (3391), Ophthalmic Goods Manufacturing (339115), Ophthalmic Goods Merchant Wholesalers (423460), Medical, Dental, and Hospital Equipment and Supplies Merchant Wholesalers (42345)
- SIC
- Surgical & Medical Instruments & Apparatus (3841), Ophthalmic Goods (3851), Wholesale-Medical, Dental & Hospital Equipment & Supplies (5047)
- akta.pro industry
- Surgical Stapling, Suturing & Hemostasis (Staplers, Clips, Sealants, Tourniquets)Healthcare & Life Sciences/Medical Devices & Diagnostics/Surgical Instruments, Endoscopy & OR EquipmentOpen & Minimally Invasive Surgical Instruments (Handheld, Laparoscopic, MIS)Healthcare & Life Sciences/Medical Devices & Diagnostics/Surgical Instruments, Endoscopy & OR EquipmentMedical, Dental & Lab Supply Marketplaces
Keywords
Where Angiotech Pharmaceuticals is headquartered
LocationHeadquarters
- HQ city
- Vancouver
- HQ country
- Canada
- HQ region
- North America
Offices3 records
Markets served
Angiotech Pharmaceuticals business model
Business model- GTM type
- B2B
- Offering type
- Hardware or Manufacturing
- Cost components
- Supply Chain, Personnel, Operations, Technology or R&D, Marketing or Sales, Infrastructure
Revenue model
- Medical Device Sales: Sale of surgical medical devices and instruments across four product categories: Biosurgery (hemostasis and sealing), Biomedical Textiles, Ophthalmology, and Wound Closure. Revenue model is primarily one-time product sales to healthcare providers, surgical centers, and hospitals.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Unit Pricing | Pay-as-you-go | B2B medical device sales to healthcare providers |
Go-to-market motion1 record
Distribution channels4 records
Marketing channels6 records
Angiotech Pharmaceuticals product offering
Product offeringCore offering
Angiotech's medical technology business, now operating as Corza Medical, manufactures and sells surgical medical devices across four product verticals: Biosurgery (TachoSil hemostatic sealants), Biomedical Textiles (Pearsalls OEM textiles), Ophthalmology (Katena instruments, SensorTek ROP Kit, Onatec sutures), and Wound Closure (Quill barbed sutures, Express Gut, Sharpoint sutures). Products are sold to hospitals, surgical centers, ophthalmology practices, and individual healthcare professionals via direct field sales, e-commerce stores, and a digital customer portal in 80+ countries.
Product overview
Corza Medical is a global medical technology company offering a unified portfolio of surgical products across four core categories: Biosurgery (hemostasis and sealing products like TachoSil), Biomedical Textiles (Pearsalls OEM products), Ophthalmology (Katena instruments, SensorTek ROP Kit, Onatec sutures), and Wound Closure (Quill barbed sutures, Express Gut, Sharpoint sutures). The company operates manufacturing across seven global locations and serves customers in 80+ countries through both direct sales and online stores.
Differentiator
Problem solved
Functional benefit
Brands
- TachoSil: Surgical hemostatic sealants used in surgery's most critical moments
- Katena
- Onatec
- Quill
- Express Gut
- Sharpoint
- SensorTek
Products and services
- TachoSil Biosurgical sealant pad used for hemostasis and tissue sealing during surgery, intended for hospitals, surgical centers, and surgeons in operative settings.
- Quill Barbed Sutures Self-anchoring barbed suture product line for wound closure in surgical procedures, used by general, orthopedic, and cosmetic surgeons.
- Katena Reusable Instruments Reusable ophthalmic surgical instruments used by ophthalmologists and eye care professionals for eye surgery, with a 50-year brand heritage.
- SensorTek ROP Kit First and only single-use kit with integrated lens designed for retinopathy of prematurity (ROP) exams, used by ophthalmologists, optometrists, and neonatal care teams.
- Onatec Ophthalmic Suture Portfolio Expanded ophthalmic suture portfolio offering microsurgical sutures for eye surgery, targeted at ophthalmologists and microsurgeons.
- Express Gut Absorbable surgical suture marketed as an affordable alternative to other brands without sacrificing needle quality, used by practicing surgeons.
- Sharpoint Sutures Surgical sutures with quality positioned as equivalent to major brands like Ethicon, used in surgical centers by orthopedic and general surgeons.
- Pearsalls Biomedical Textiles Biomedical textile products supplied to OEM partners for medical device prototyping and textile-based product development.
Quantifiable outcome
- 1000+ students and optometrists trained through Corza's medical education support
Companies that use Angiotech Pharmaceuticals
Customer profileNamed customers3 records
Segments4 records
Ideal customer profiles4 records
Angiotech Pharmaceuticals technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature7 records
Angiotech Pharmaceuticals partnerships and signals
Strategic signalScale indicators5 records
Recent moves6 records
Expansion highlights5 records
Angiotech Pharmaceuticals competitors and assessment
Company assessmentDirect peers
- Ethicon (Johnson & Johnson MedTech): The dominant global sutures, wound closure, and biosurgery franchise; Sharpoint is explicitly benchmarked against Ethicon in surgeon testimonials, making this the most direct comparable for Corza's wound closure and hemostasis business.
- Becton, Dickinson and Company (BD): Large diversified medical device maker with material exposure to surgical instruments, sutures, and ophthalmic surgical products; directly competes with Corza across reusable instruments and procedural consumables.
- Smith+Nephew: Global medical device company with a meaningful wound closure, surgical instrumentation, and orthopedics portfolio; comparable for surgical consumables, sports medicine/orthopedic wound closure, and hospital-channel sales motion.
- Integra LifeSciences: Specialty surgical devices and instruments company with strong presence in reusable surgical instruments and tissue technologies; comparable to Corza's Katena and TachoSil-style surgical adjacencies.
- CONMED: Specialty medical device company focused on general surgery, orthopedics, and ophthalmology; comparable given overlapping call points in surgical centers and ophthalmic procedural devices.
- BVI Medical (Beaver-Visitec International): Specialist in ophthalmic surgical instruments, IOLs, and single-use eye surgery consumables; the most direct niche comparable to Corza's Katena and SensorTek ophthalmology portfolio.
Broad incumbents
- Medtronic: Broad incumbent in surgical instruments and operating-room solutions with overlapping reach into hospitals and ambulatory surgical centers; comparable as a multi-vertical surgical device competitor with global distribution.
- Stryker: Large diversified surgical and medical device incumbent with hospital sales coverage that overlaps Corza's surgical-center and operating-room footprint, particularly in instruments and surgical adjacencies.
- Boston Scientific: Diversified medical device incumbent with procedural and surgical adjacencies; relevant for benchmarking a multi-vertical surgical device business with global hospital coverage.
- Abbott: Large diversified medtech incumbent with hospital channel reach and adjacent device franchises; useful as a benchmark for size, channel power, and global manufacturing footprint comparable to Corza's.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat6 records
Key risks6 records
Key highlights7 records
Customer concentration
Angiotech Pharmaceuticals social profiles
Digital presenceAngiotech Pharmaceuticals financial estimates
Financial estimateRevenue estimate
Valuation estimate
Angiotech Pharmaceuticals leadership team
Management profileNumber of profiles
Profiles1 record
Angiotech Pharmaceuticals subsidiaries and ownership
Company hierarchySubsidiaries1 record
Angiotech Pharmaceuticals funding detail
Funding detailFunding overview
Funding rounds1 record
Investors8 records
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Angiotech Pharmaceuticals M&A and investment
M&A and investmentM&A3 records
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Angiotech Pharmaceuticals
What does Angiotech Pharmaceuticals do?
Angiotech's medical technology business, now operating as Corza Medical, manufactures and sells surgical medical devices across four product verticals: Biosurgery (TachoSil hemostatic sealants), Biomedical Textiles (Pearsalls OEM textiles), Ophthalmology (Katena instruments, SensorTek ROP Kit, Onatec sutures), and Wound Closure (Quill barbed sutures, Express Gut, Sharpoint sutures). Products are sold to hospitals, surgical centers, ophthalmology practices, and individual healthcare professionals via direct field sales, e-commerce stores, and a digital customer portal in 80+ countries.
Is Angiotech Pharmaceuticals a public or private company?
Angiotech Pharmaceuticals is a private company. It is classified as private equity controlled and is currently operating.
When was Angiotech Pharmaceuticals founded?
Angiotech Pharmaceuticals was founded in 1975. It employs 1,001 to 5,000 people.
Where is Angiotech Pharmaceuticals based?
Angiotech Pharmaceuticals is headquartered in Vancouver, Canada, in the North America region.
How does Angiotech Pharmaceuticals make money?
One revenue line is on record: medical Device Sales.
Who are Angiotech Pharmaceuticals's main competitors?
Direct peers on record are Ethicon (Johnson & Johnson MedTech), Becton, Dickinson and Company (BD), Smith+Nephew, Integra LifeSciences, CONMED and BVI Medical (Beaver-Visitec International). Broad incumbents are Medtronic, Stryker, Boston Scientific and Abbott.
Does Angiotech Pharmaceuticals have an API?
No public API is recorded for Angiotech Pharmaceuticals.
What industry is Angiotech Pharmaceuticals in?
Angiotech Pharmaceuticals's product category is Surgical Medical Devices. Its primary akta.pro industry code is HLAHADAL, Surgical Stapling, Suturing & Hemostasis (Staplers, Clips, Sealants, Tourniquets), with a secondary code of HLAHADAA, Open & Minimally Invasive Surgical Instruments (Handheld, Laparoscopic, MIS). Its NAICS code is 339112 and its SIC code is 3841.